TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100166,159.91+0.12%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.50+0.34%Gold$4,122.96−0.43%Brent$110.19+0.89%BTC$81,775.70−0.08%ETH$2,399.18−0.25%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100166,159.91+0.12%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.50+0.34%Gold$4,122.96−0.43%Brent$110.19+0.89%BTC$81,775.70−0.08%ETH$2,399.18−0.25%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Open

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Greenwich LifeSciences Inc · Overview · TradingHolo

Markets › United States › NAS › GLSI

G

Greenwich LifeSciences Inc

NAS:GLSIHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$15.21+4.54%At closeAt close · Tue 20 Oct · ≈ AED 55.86 · Market cap $223.26M · Next earnings Fri 13 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

+4.5%

1M

−19.9%

3M

+3.8%

6M

−38.0%

1Y

+56.5%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

GLSI +4.54% today

✦ This week in three lines

No written digest yet for GLSI. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR —

Valuation

P/E vs sector−11.5× vs −1.7×

Price / Book vs sector632.1× vs 2.0×

Price / Sales vs sector—

Price / Free cash flow vs sector−22.5× vs −1.5×

Forecasts

2 buy0 hold0 sell2 analysts

Average target$0.0000 −100.0%

Analysts0

EPS surprises, last 82 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All GLSI news →

GLGreenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027

GlobeNewsWire · 71 d ago

Key facts

At close · Tue 20 Oct

Market cap (USD)$223.26M

P/E−11.5×

Dividend yield0.0%

52-week range$7.78 – $34.10

Avg volume (20d)131,244

Shares outstanding14,678,200

Beta1.45

Short interest20.7% of float

Next earningsFri 13 Nov

Radar Score

32

Value31

Quality0

Momentum51

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×−1.33%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×−0.69%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×−0.96%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×+1.36%